Neuroendovascular Coil Market Size, Share, and COVID-19 Impact Analysis, By Type (Bare Metal Coils, Hydrogel Coated Coils, and Others), By Application (Cerebral Infarction, Cerebral Aneurysm, Arteriovenous Malformation (AVM), and Others), By End-User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast till 2032

Neuroendovascular coiling is a procedure performed to block the blood flow into an aneurysm. Neuroendovascular coils are medical devices used in the treatment of cerebral aneurysms and other vascular abnormalities within the brain. An aneurysm is a bulge and weak area in the wall of a blood vessel. The rupture of aneurysms causes life-threatening blood loss and brain damage. The coils prevent blood flow into the aneurysm and prevent it from getting ruptured.

The neuroendovascular coils are designed to be delivered into the aneurysm through a minimally invasive procedure. An increase in the number of patients suffering from brain aneurysms is the major factor contributing to the growth of the neuroendovascular coil market.

• According to data published by the World Health Organization (WHO) in 2023, around 15.0 million people worldwide suffer a stroke and coiling procedures are required to be performed to avoid permanent disability.

Furthermore, an increase in research and development initiatives by market players and government approvals for the manufacturing and sales of neuroendovascular coils for neurovascular interventional treatment is expected to fuel the growth of the market.

• For instance, in August 2022, MicroPort Neurotech Limited, a well-renowned Chinese company in the field of neurovascular interventional treatment, received marketing approval for Numen Coil Embolization System by the Ministry of Health, Labour and Welfare, Japan to treat intracranial aneurysms in Japan.

Impact of COVID-19 on the Neuroendovascular Coil Market

The COVID-19 pandemic had a negative impact on the neuroendovascular coil market in 2020. The impact accounted for a decline in neurological surgeries as hospitals prioritized emergency cases and essential treatments.

• According to data published in the Neurological Focus journal in December 2020, a survey conducted in the neurosurgical departments of the Veneto region of Italy showed a 49.0% and 27.0% decrease in coiling procedures for unruptured and ruptured aneurysms respectively in hospitals during the pandemic.

Moreover, reduced patient visits to healthcare facilities for non-urgent conditions significantly decreased the demand for neuroendovascular procedures and negatively impacted the market during the pandemic.

Disruptions in the supply chain and redirection of focus of medical device manufacturing companies toward ensuring COVID-19 supplies disrupted the neuroendovascular coil market.

However, the market stabilized in 2021 with the resumption of neurological surgeries and hospital visits and is anticipated to expand at a rapid pace over the forecast period.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Neuroendovascular Diseases, By Key Countries/ Regions, 2022


• New Product Launches By Key Players


• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)


• Impact of COVID-19 on the Market

Analysis by Type

Based on type, the bare metal coils accounted for a significant proportion of the global neuroendovascular coil market in 2022. The segment growth is attributed to constant innovation and the development of advanced metal coils. Besides, the coils are safe and effective which enhances their adoption in the market.

• In December 2022, Stryker announced 510k clearance for their target tetra detachable coil made up of platinum-tungsten alloy. This coil combines a new tetrahedral shape and possesses a softness level specifically designed to treat small aneurysms.

Furthermore, the rise of minimally invasive procedures for neuroendovascular diseases in developed and developing nations is estimated to drive segmental growth over the forecast period.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America dominated the neuroendovascular coil market in 2022 and is projected to maintain its position over the forecast period. The growth is mainly credited to a rise in the number of new and existing cases of brain aneurysms in America.

• For instance, according to data published by the Brain Aneurysm Foundation, around 6.7 million people in the U.S. suffered from an unruptured brain aneurysm in 2022, and about 30,000 people in the country suffered a brain aneurysm rupture each year.

In addition, the robust growth of technology in the healthcare sector and increasing product launches, coupled with the rising level of research and development, are driving the growth of the market in North America.

Key Players Covered

The report includes the profiles of key players such as Stryker, Balt, Terumo Corporation, Medtronic, Johnson & Johnson Services, Inc. (J&J MedTech), Penumbra, Inc., Boston Scientific Corporation, and others.

Key Industry Developments

• In June 2023, Boston Scientific Corporation received FDA 510(k) clearance for their Embold Soft and Packing coils, which have been designed for use in various embolization procedures.


• In May 2023, Medical Device Business Services, Inc. (J&J MedTech) announced the commercial launch of its new CEREPAK Detachable Coils, which is used to treat brain aneurysms, in the U.S. market.


• In May 2023, Stryker announced the acquisition of Cerus Endovascular, a medical device company involved in neuro interventional devices, to expand its product portfolio for the treatment of intracranial aneurysms.